Drug Interactions and Adverse Effects in Critical Illness

Critically ill patients typically receive many medications at once while their organ function is changing, which makes them especially prone to drug interactions and adverse drug effects. A drug interaction occurs when one drug alters the effect of another — or of food or a disease state — while an adverse effect is an unintended and harmful response to a medication; both are common sources of preventable harm in intensive and emergency care.

Definition

Drug interactions and adverse effects in critical illness are the altered or unintended responses to medication that arise when drugs influence one another or the body, made more frequent and consequential by polypharmacy and by the changes in drug handling that accompany organ dysfunction in critically ill patients.

Scope

The topic covers why interactions and adverse effects are amplified in critical illness: polypharmacy, altered pharmacokinetics from organ dysfunction, and the narrow margins of high-alert drugs. It distinguishes pharmacokinetic from pharmacodynamic interactions, introduces adverse drug events and reactions, and notes monitoring and reconciliation as safeguards. It is a reference and educational overview and does not provide dosing, agent-selection, or treatment recommendations for individual patients.

Core questions

• Why are drug interactions and adverse effects more common and more serious in critically ill patients?
• How do pharmacokinetic interactions differ from pharmacodynamic ones?
• What surveillance and reconciliation practices help detect and prevent medication-related harm?

Key concepts

• Pharmacokinetic versus pharmacodynamic interactions
• Polypharmacy
• Adverse drug events and adverse drug reactions
• Altered organ function (renal, hepatic) and drug handling
• Therapeutic drug monitoring
• Medication reconciliation
• Toxidromes and drug toxicity

Mechanisms

Interactions arise pharmacokinetically when one agent changes the absorption, distribution, metabolism, or excretion of another — for example by inhibiting or inducing metabolic enzymes — and pharmacodynamically when drugs with additive or opposing effects act on the same system. Critical illness magnifies both: organ dysfunction alters clearance and protein binding, so concentrations drift more unpredictably, and the number of concurrent high-alert drugs increases the chances of harmful combinations. Adverse drug events range from predictable, dose-related toxicity to idiosyncratic reactions and recognizable toxidromes. Monitoring of drug levels and physiologic effects, along with medication reconciliation, helps detect and limit these problems.

Clinical relevance

Surveillance for adverse effects and interactions is woven through critical care nursing: nurses administer multiple high-alert drugs, observe for expected and unexpected responses, track relevant laboratory values, and contribute to medication reconciliation at transitions of care. Systematic review evidence indicates that adverse drug reactions account for a meaningful share of hospital admissions, underscoring the importance of this vigilance. This entry describes how medication safety is organized and is not a source of dosing or individualized treatment advice.

Epidemiology

A systematic review of prospective observational studies found that adverse drug reactions accounted for a substantial proportion of hospital admissions, establishing them as an important and partly preventable cause of harm. Within critical care, the combination of polypharmacy and organ dysfunction is generally understood to raise this risk further, though precise rates vary by setting and method.

Evidence & guidelines

The topic draws on systematic-review evidence on adverse drug reactions, reviews of altered drug handling in critical illness and of toxidrome assessment, and disease-specific reviews such as the coagulopathy of liver disease that illustrate how organ dysfunction reshapes drug effects. These are reference sources describing how care is generally organized rather than directives for an individual patient.

History

As pharmacology matured, recognition grew that medications cause a substantial and partly preventable burden of harm, giving rise to pharmacovigilance and to the study of drug-drug interactions. In critical care, the layering of many potent drugs on top of failing organs made this concern especially acute, and systematic syntheses such as that by Kongkaew and colleagues quantified the contribution of adverse drug reactions to hospital admissions.

Seminal works

• kongkaew-2008
• roberts-2014

Frequently asked questions

What is the difference between a drug interaction and an adverse effect?

A drug interaction occurs when one drug changes the effect of another drug, or of food or a disease, making it stronger, weaker, or different. An adverse effect is any unintended and harmful response to a medication, which may or may not result from an interaction.

Why are critically ill patients at higher risk of medication-related harm?

They usually receive many medications at the same time, several of them high-alert, while their kidney, liver, and circulatory function may be changing. These factors make drug levels less predictable and harmful interactions and adverse effects more likely, which is why close monitoring and medication reconciliation are emphasized.